Last reviewed · How we verify
TX200-TR101
At a glance
| Generic name | TX200-TR101 |
|---|---|
| Also known as | CAR-Tregs |
| Sponsor | Sangamo Therapeutics |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
- Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |